Last Price
0.29
Today's Change
+0.002 (0.69%)
Day's Change
0.274 - 0.299
Trading Volume
357,596
Exchange: NASDAQ Capital Market NASDAQ Capital Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Dr. Meeshanthini V. Dogan Ph.D. Dr. Meeshanthini V. Dogan Ph.D.
Full Time Employees: 7 7
IPO Date: 2022-01-14 2022-01-14
CIK: 0001870144 0001870144
ISIN: US14159C1036 US14159C1036
CUSIP: 14159C103 14159C103
Beta: 4.81 4.81
Last Dividend: 0.00 0.00
Dcf Diff: 0.29 0.29
Dcf: -0.00 -0.00
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.